References
- Chiu BC, Cerhan JR, Folsom AR, Sellers TA, Kushi LH, et al.: Diet and risk of non-Hodgkin lymphoma in older women. JAMA 275(17), 1315–1321, 1996.
- Chang ET, Balter KM, Torrang A, Smedby KE, Melbye M, et al.: Nutrient intake and risk of non-Hodgkin’s lymphoma. Am J Epidemiol 164(12), 1222–1232, 2006.
- Charbonneau B, O'Connor HM, Wang AH, Liebow M, Thompson CA, et al.: Trans fatty acid intake is associated with increased risk and n3 fatty acid intake with reduced risk of non-Hodgkin lymphoma. J Nutr 143(5), 672–681, 2013.
- Fritschi L, Ambrosini GL, Kliewer EV, and Johnson KC: Dietary fish intake and risk of leukaemia, multiple myeloma, and non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 13(4), 532–537, 2004.
- Cvetkovic Z, Vucic V, Cvetkovic B, Petrovic M, Ristic-Medic D, et al.: Abnormal fatty acid distribution of the serum phospholipids of patients with non-Hodgkin lymphoma. Ann Hematol 89(8), 775–782, 2010.
- Cvetković Z, Vučić V, Cvetković B, Karadžić I, Ranić M, et al.: Distribution of plasma fatty acids is associated with response to chemotherapy in non-Hodgkin’s lymphoma patients. Med Oncol 30(4), 1–7, 2013.
- Maurer MJ, Ghesquieres H, Jais JP, Witzig TE, Haioun C, et al.: Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy. J Clin Oncol 32(10), 1066–1073, 2014.
- The International Non-Hodgkin’s Lymphoma Prognostic Factors Project: A predictive model for aggressive Non-Hodgkin’s Lymphoma. N Engl J Med 329(14), 987–994, 1993.
- Maurer MJ, Jais JP, Ghesquieres H, Witzig TE, Hong F, et al.: Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma. Am J Hematol 91(2), 179–184, 2016.
- Spencer L, Mann C, Metcalfe M, Webb M, Pollard C, et al.: The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential. Eur J Cancer 45(12), 2077–2086, 2009.